Bausch Health Companies Inc. Operating Lease Right-of-Use Assets
Bausch Health Companies Inc. (BHC) had Operating Lease Right-of-Use Assets of $215.00 million as of 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-02-19
- 2025-12-31: Operating Lease, Right-of-Use Asset $215.00M.
- 2024-12-31: Operating Lease, Right-of-Use Asset $211.00M.
- 2023-12-31: Operating Lease, Right-of-Use Asset $185.00M.
- 2022-12-31: Operating Lease, Right-of-Use Asset $221.00M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-12-31 | $215.00M 10-K · filed 2026-02-19 |
| 2024-12-31 | $211.00M 10-K · filed 2026-02-19 |
| 2023-12-31 | $185.00M 10-K · filed 2025-02-20 |
| 2022-12-31 | $221.00M 10-K · filed 2024-02-22 |
| 2021-12-31 | $247.00M 10-K · filed 2023-02-23 |
| 2020-12-31 | $259.00M 8-K · filed 2022-05-11 |
| 2019-12-31 | $271.00M 8-K · filed 2021-05-04 |
| 2019-09-30 | $263.00M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $263.00M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $274.00M 10-Q · filed 2019-05-06 |
| 2019-01-01 | $302.00M 8-K · filed 2021-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |